Catch up on the top radiology content of the past week.
|Articles|November 3, 2010
- Diagnostic Imaging Vol 32 No 10
- Volume 32
- Issue 10
Imaging technique proves useful for ovarian cancer
A molecular imaging technique may prove useful in early assessment of treatment response for cisplatin-resistant ovarian cancer, according to a study published in the Journal of Nuclear Medicine.
Advertisement
A molecular imaging technique may prove useful in early assessment of treatment response for cisplatin-resistant ovarian cancer, according to a study published in the Journal of Nuclear Medicine. Cisplatin is often effective against ovarian cancer when first given, but tumors can become resistant and start growing again.
The study showed F-18 fluorothymidine (F-FLT) PET was able to predict early response to everolimus (a mammalian target of rapamycin inhibitor) in cisplatin-resistant ovarian cancer in mice. The technique should be considered for therapeutic assessment in humans, according to the researchers.
No significant change in tumor F-FLT uptake was observed in the controls. In the everolimus-treated mice, F-FLT standard uptake value decreased by 33% on the second day of treatment and by 66% on the seventh day. There were also changes in tumor volume.
Articles in this issue
almost 16 years ago
Coronary CTA really works, but why isn't its use soaring?almost 16 years ago
Case of the Monthalmost 16 years ago
Small pulmonary emboli still stump radiologistsalmost 16 years ago
Leukemia joins radiation risks for interventionalistsalmost 16 years ago
MRI reveals when cognitive impairment will advancealmost 16 years ago
Incidental findings can predict cardiac diseasealmost 16 years ago
Delayed cardiac test saves moneyalmost 16 years ago
The deck is stacked against coronary CTA; why it mattersalmost 16 years ago
We spend on end-of-life care at expense of patientsalmost 16 years ago
LifeImage takes sting out of viewing patient CDsAdvertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears First MRI-Derived AI Software for Assessing Breast Cancer Recurrence Risk
2
Diagnostic Imaging's Weekly Scan: October 11 — October 17
3
What a Large Prostate MRI Study Reveals About AI and Unassisted Radiologist Assessment
4
How Photon-Counting CT Helps Us Recognize that Coronary Stenosis is Just One Piece of the Puzzle
5